{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:04:05Z","timestamp":1779314645336,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.bbr.2012.05.011","type":"journal-article","created":{"date-parts":[[2012,5,17]],"date-time":"2012-05-17T22:27:49Z","timestamp":1337293669000},"page":"375-381","source":"Crossref","is-referenced-by-count":22,"title":["High intake of folic acid or complex of B vitamins provides anti-Parkinsonism effect: No role for serum level of homocysteine"],"prefix":"10.1016","volume":"233","author":[{"given":"Hashem","family":"Haghdoost-Yazdi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negin","family":"Fraidouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayda","family":"Faraji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Jahanihashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Sarookhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2012.05.011_bib0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1212\/WNL.47.6_Suppl_3.161S","article-title":"Oxidative stress and the pathogenesis of Parkinson's disease","volume":"47","author":"Jenner","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2012.05.011_bib0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/exnr.2000.7489","article-title":"Increased caspase 3 and bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease","volume":"166","author":"Tatton","year":"2000","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.bbr.2012.05.011_bib0015","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ana.20509","article-title":"Methylenetetrahydrofolate reductase C677T genotype and PD","volume":"57","author":"Lau","year":"2005","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.bbr.2012.05.011_bib0020","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/archneur.64.4.576","article-title":"Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease","volume":"64","author":"Hancock","year":"2007","journal-title":"Archives of Neurology"},{"issue":"12","key":"10.1016\/j.bbr.2012.05.011_bib0025","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nature Neuroscience"},{"issue":"6","key":"10.1016\/j.bbr.2012.05.011_bib0030","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/archneur.1997.00550180070015","article-title":"Dietary antioxidants and Parkinson disease. The Rotterdam Study","volume":"54","author":"de Rijk","year":"1997","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.bbr.2012.05.011_bib0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000007984","article-title":"Elevated plasma levels of homocysteine in Parkinson's disease","volume":"40","author":"Kuhn","year":"1998","journal-title":"European Neurology"},{"key":"10.1016\/j.bbr.2012.05.011_bib0040","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1001\/archneur.57.10.1422","article-title":"Homocysteine and neurologic disease","volume":"57","author":"Diaz-Arrastia","year":"2000","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.bbr.2012.05.011_bib0045","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.61.6.865","article-title":"Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations","volume":"61","author":"O\u2019 Suilleabhain","year":"2004","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.bbr.2012.05.011_bib0050","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1212\/01.WNL.0000032494.05619.93","article-title":"Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study","volume":"59","author":"Prins","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2012.05.011_bib0055","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1515\/CCLM.2005.191","article-title":"Homocysteine and B vitamins in mild cognitive impairment and dementia","volume":"43","author":"Quadri","year":"2005","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"10.1016\/j.bbr.2012.05.011_bib0060","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer's disease","volume":"346","author":"Seshadri","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.bbr.2012.05.011_bib0065","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1515\/CCLM.2001.120","article-title":"Homocysteine in cerebrovascular disease: an independent risk factor for subcortical vascular encephalopathy","volume":"39","author":"Bertsch","year":"2001","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"10.1016\/j.bbr.2012.05.011_bib0070","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1176\/appi.ajp.159.12.2099","article-title":"Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study","volume":"159","author":"Tiemeier","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"11","key":"10.1016\/j.bbr.2012.05.011_bib0075","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1073\/pnas.94.11.5923","article-title":"Neurotoxicity associated with dual actions of homocysteine at the N-methyl-d-aspartate receptor","volume":"94","author":"Lipton","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"18","key":"10.1016\/j.bbr.2012.05.011_bib0080","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1523\/JNEUROSCI.20-18-06920.2000","article-title":"Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity","volume":"20","author":"Kruman","year":"2000","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2012.05.011_bib0085","first-page":"527","article-title":"Sulfate and cysteine levels in the plasma of patients with Parkinson's disease","volume":"16","author":"Allain","year":"1995","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbr.2012.05.011_bib0090","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1212\/WNL.55.3.437","article-title":"Plasma homocysteine and MTHFR C677T genotype in levodopa treated patients with PD","volume":"55","author":"Yasui","year":"2000","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.bbr.2012.05.011_bib0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11011-009-9139-4","article-title":"Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson's disease","volume":"24","author":"dos Santos","year":"2009","journal-title":"Metabolic Brain Disease"},{"key":"10.1016\/j.bbr.2012.05.011_bib0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.0022-3042.2001.00676.x","article-title":"Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease","volume":"80","author":"Duan","year":"2002","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.bbr.2012.05.011_bib0105","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1212\/WNL.58.10.1539","article-title":"Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals","volume":"58","author":"Sachdev","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2012.05.011_bib0110","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/j.febslet.2006.04.088","article-title":"Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia","volume":"580","author":"Obeid","year":"2006","journal-title":"FEBS Letters"},{"issue":"1","key":"10.1016\/j.bbr.2012.05.011_bib0115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1007-4376(08)60003-9","article-title":"Effect and mechanism of homocysteine on Parkinson's disease induced by 6-OHDA","volume":"22","author":"Xing","year":"2008","journal-title":"Journal of Nanjing Medical University"},{"key":"10.1016\/j.bbr.2012.05.011_bib0120","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ajcn\/73.3.613","article-title":"Determinants of plasma total homocysteine in the Framingham Offspring cohort","volume":"73","author":"Jacques","year":"2001","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1016\/j.bbr.2012.05.011_bib0125","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1124\/pr.54.4.599","article-title":"Homocysteine determinants and the evidence to what extent homocysteine determinants the risk of coronary heart disease","volume":"54","author":"de Bree","year":"2002","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.bbr.2012.05.011_bib0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10545-006-0106-5","article-title":"Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview","volume":"29","author":"Castro","year":"2006","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1016\/j.bbr.2012.05.011_bib0135","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/jn\/136.6.1726S","article-title":"The many facets if hiperhomocysteinemia: studies from the Framingham Cohorts","volume":"136","author":"Selhub","year":"2006","journal-title":"Journal of Nutrition"},{"key":"10.1016\/j.bbr.2012.05.011_bib0140","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1161\/01.STR.26.7.1166","article-title":"Serum folate and risk for ischemic stroke. First National Health and Nutrition Examination Survey epidemiologic follow-up study","volume":"26","author":"Giles","year":"1995","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.bbr.2012.05.011_bib0145","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ajcn\/75.4.616","article-title":"High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): relevance to genetic disease and polymorphisms","volume":"75","author":"Ames","year":"2002","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1016\/j.bbr.2012.05.011_bib0150","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.neurobiolaging.2008.05.031","article-title":"Synergistic anti-Parkinsonism activity of high doses of B vitamins in a chronic cellular model","volume":"31","author":"Jia","year":"2010","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.bbr.2012.05.011_bib0155","unstructured":"Nutrient requirements of laboratory animals, Fourth Revised Edition. National Academy Press, Washington, D.C; 1995."},{"key":"10.1016\/j.bbr.2012.05.011_bib0160","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.bbr.2012.05.011_bib0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0169-328X(96)00018-6","article-title":"Expression of dopamine transporter mRNA and its binding site in fetal nigral cells transplanted into the striatum of 6-OHDA lesioned rat","volume":"39","author":"Fujita","year":"1996","journal-title":"Molecular Brain Research"},{"issue":"1","key":"10.1016\/j.bbr.2012.05.011_bib0170","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0006-8993(95)00150-O","article-title":"Asymmetrical motor behavior in rats with unilateral striatal excitotoxic lesions as revealed by the elevated body swing test","volume":"676","author":"Borlongan","year":"1995","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2012.05.011_bib0175","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1471-4914(03)00117-5","article-title":"Disease model: Parkinson's disease","volume":"9","author":"Shimohama","year":"2003","journal-title":"Trends in Molecular Medicine"},{"issue":"6","key":"10.1016\/j.bbr.2012.05.011_bib0180","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.bbr.2012.05.011_bib0185","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneumeth.2004.10.004","article-title":"Histological, behavioral and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease","volume":"144","author":"Yuan","year":"2005","journal-title":"Journal of Neuroscience Methods"},{"issue":"1","key":"10.1016\/j.bbr.2012.05.011_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2005.02.023","article-title":"Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice","volume":"162","author":"Iancu","year":"2005","journal-title":"Behavioural Brain Research"},{"issue":"7","key":"10.1016\/j.bbr.2012.05.011_bib0195","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1523\/JNEUROSCI.15-07-05372.1995","article-title":"Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism","volume":"15","author":"Borlongan","year":"1995","journal-title":"Journal of Neuroscience"},{"issue":"1","key":"10.1016\/j.bbr.2012.05.011_bib0200","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0306-4522(97)00498-3","article-title":"Behavioural recovery after unilateral lesion of the dopaminergic mesotelencephalic pathway: effect of repeated testing","volume":"84","author":"Abrous","year":"1998","journal-title":"Neuroscience"},{"issue":"4-5","key":"10.1016\/j.bbr.2012.05.011_bib0205","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0031-9384(02)00753-9","article-title":"Efficacy of elevated body swing test in the early model of Parkinson's disease in rat","volume":"76","author":"Roghani","year":"2002","journal-title":"Physiology and Behavior"},{"issue":"9","key":"10.1016\/j.bbr.2012.05.011_bib0210","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1017\/S0007114510005052","article-title":"Changes in dietary folate intake differentially affect oxidized lipid and mitochondrial DNA damage in various brain regions of rats in the absence\/presence of intracerebroventricularly injected amyloid b-peptide challenge","volume":"105","author":"Chen","year":"2011","journal-title":"British Journal of Nutrition"},{"key":"10.1016\/j.bbr.2012.05.011_bib0215","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1212\/WNL.47.3.644","article-title":"Diet and Parkinson's disease. II: a possible role for the past intake of specific nutrients. Results from a self-administered food frequency questionnaire in a case-control study","volume":"47","author":"Hellenbrand","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2012.05.011_bib0220","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/aje\/kwh213","article-title":"Folate intake and risk of Parkinson's disease","volume":"160","author":"Chen","year":"2004","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.bbr.2012.05.011_bib0225","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1016\/j.lfs.2004.12.011","article-title":"Physiological variation in plasma total homocysteine concentrations in rats","volume":"76","author":"Martins","year":"2005","journal-title":"Life Sciences"},{"key":"10.1016\/j.bbr.2012.05.011_bib0230","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jns.2006.05.040","article-title":"Homocysteine serum levels and MTHFH C677T genotyoe in patients with Parkinson's disease, with and without levopoda therapy","volume":"248","author":"Todorovic","year":"2006","journal-title":"Journal of the Neurological Sciences"},{"issue":"1","key":"10.1016\/j.bbr.2012.05.011_bib0235","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00002826-199702000-00007","article-title":"Effect of l-dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats","volume":"20","author":"Miller","year":"1997","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.bbr.2012.05.011_bib0240","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2006.05.040","article-title":"Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in patients with Parkinson's disease","volume":"404","author":"Religa","year":"2006","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.bbr.2012.05.011_bib0245","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneur.60.1.59","article-title":"Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease","volume":"60","author":"Rogers","year":"2003","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.bbr.2012.05.011_bib0250","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.tins.2004.06.008","article-title":"Smoking, nicotine and Parkinson's disease","volume":"27","author":"Quik","year":"2004","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.bbr.2012.05.011_bib0255","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/10284150600583446","article-title":"Role of lifestyle factors on plasma homocysteine levels in Pakinson's disease patients treated with levodopa","volume":"9","author":"Siniscalchi","year":"2006","journal-title":"Nutritional Neuroscience"},{"issue":"1\u20132","key":"10.1016\/j.bbr.2012.05.011_bib0260","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-2999(02)01452-8","article-title":"The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets","volume":"441","author":"Rommelspacher","year":"2002","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"10.1016\/j.bbr.2012.05.011_bib0265","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbrc.2004.11.033","article-title":"Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors","volume":"326","author":"Herraiz","year":"2005","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"9","key":"10.1016\/j.bbr.2012.05.011_bib0270","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/clinchem\/39.9.1764","article-title":"Total homocysteine in plasma or serum: methods and clinical applications","volume":"39","author":"Ueland","year":"1993","journal-title":"Clinical Chemistry"},{"issue":"50","key":"10.1016\/j.bbr.2012.05.011_bib0275","doi-asserted-by":"crossref","first-page":"19995","DOI":"10.1073\/pnas.0709487104","article-title":"In vitamin B12 deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concentrations","volume":"104","author":"Selhub","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/j.bbr.2012.05.011_bib0280","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.3945\/ajcn.2009.27514","article-title":"Metabolic evidence of vitamin B-12 deficiency, including high homocysteine and methylmalonic acid and low holotranscobalamin, is more pronounced in older adults with elevated plasma folate","volume":"90","author":"Miller","year":"2009","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1016\/j.bbr.2012.05.011_bib0285","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.nutr.19.1.217","article-title":"Homocysteine metabolism","volume":"19","author":"Selhub","year":"1999","journal-title":"Annual Review of Nutrition"},{"issue":"10","key":"10.1016\/j.bbr.2012.05.011_bib0290","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/mds.22522","article-title":"Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study","volume":"24","author":"Rodriguez-Oroz","year":"2009","journal-title":"Movement Disorders"},{"key":"10.1016\/j.bbr.2012.05.011_bib0295","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1460-9568.2008.06356.x","article-title":"Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism","volume":"28","author":"Anderson","year":"2008","journal-title":"European Journal of Neuroscience"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432812003324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432812003324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T20:32:44Z","timestamp":1594153964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432812003324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0166432812003324"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2012.05.011","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}